Costimulation in Tolerance and Autoimmunity

References

• Linsley P. S., Ledbetter J. A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol 1993; 11: 191–212
   PubMed Web of Science ®Google Scholar
• June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321–331
   PubMedGoogle Scholar
• Jenkins M., Taylor P., Norton S., Urdahl K. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol 1991; 147: 2461–2466
   PubMed Web of Science ®Google Scholar
• Harding F. A., McArthur J. G., Gross J. A., Raulet D. H., Allison J. P. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992; 356: 607–609
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med 1991; 173: 721–730
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Clark E. A., Ledbetter J. A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB1. Proc. Natl. Acad. Sci. USA 1990; 87: 5031–5035
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Brady W., Urnes M., Grosmaire L. S., Damle N. K., Ledbetter J. A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med 1991; 174: 561–569
   PubMed Web of Science ®Google Scholar
• Azuma M., Ito D., Yagita H., Okumura K., Phillips J. H., Lanier L. L., Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76–79
   PubMed Web of Science ®Google Scholar
• Freeman G. J., Gibben J. G., Boussiotis V. A., Ng J. W., Lombard L. A., Gray G. S., Nadler L. M. Cloning of B7–2: A CTLA-4 counter receptor that costimulates human T cell proliferation. 1993. Science 1993; 262: 909–911
   PubMed Web of Science ®Google Scholar
• Hathcock K., Laszlo G., Dickler H., Bradshaw J., Linsley P., Hodes R. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993; 262: 905–907
   PubMed Web of Science ®Google Scholar
• Freeman G. J., Gray G. S., Gimmi C. D., Lombard D. B., Zhou L. -J., White M., Fingeroth J. D., Gribben J. G., Nadler L. M. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med 1991; 174: 625–631
   PubMed Web of Science ®Google Scholar
• Galvin F., Freeman G. J., Razi-Wolf Z., Hall W., Benacerraf B., Nadler L., Reiser H. 1992. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J. Immunol 1992; 149: 3802–3808
   PubMedGoogle Scholar
• Reiser H., Freeman G. J., Razi-Wolf Z., Gimmi C. D., Benacerraf B., Nadler L. M. Murine B7 antigen provides an efficient costimulatory signal for the activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl. Acad. Sci. USA 1992; 89: 271
   PubMedGoogle Scholar
• Koulova L., Clark E. A., Shu G., Dupont B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J. Exp. Med 1991; 173: 759–762
   PubMed Web of Science ®Google Scholar
• Razi-Wolf Z., Galvin F., Gray G., Reiser H. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc. Natl. Acad. Sci. USA 1993; 90: 11182–11186
   PubMedGoogle Scholar
• Thompson C. B., Lindsten T., Ledbetter J. A., Kunkel S. L., Young H. A., Emerson S. G., Leiden J. M., June C. CD28 activation pathway regulates the production of multiple T cell derived lymphokines/ cytokines. Proc. Natl. Acad. Sci. USA 1989; 86: 1333–1337
   PubMed Web of Science ®Google Scholar
• Seder R. A., Grmain R. N., Linsley P. S., Paul W. E. CD28-mediated Costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med 1994; 179: 299–304
   PubMed Web of Science ®Google Scholar
• Harding F., Allison J. CD28-B7 Interactions Allow the Induction of CD28+ Cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med 1993; 177: 1791–1796
   PubMed Web of Science ®Google Scholar
• Tan R., Teh S. J., Ledbetter J. A., Linsley P. S., Teh H. S. B7 costimulates proliferation of CD4 CD8+ T lymphocytes but is not required for the deletion of immature CD4+CD8+ thymocytes. J. Immunol 1992; 149: 3217–3224
   PubMedGoogle Scholar
• Azuma M., Cayabyab M., Phillips J. H., Lanier L. L. Requirements for the CD28-dependent T cell-mediated cytotoxicity. J. Immunol 1993; 150: 2091–2101
   PubMed Web of Science ®Google Scholar
• Lanier L. L., O'Fallon S., Somoza C., Phillips J. H., Linsley P. S., Okumura K., Ito D., Azuma M. CD80 (B7) and CD86 (B70) procide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol 1995; 154: 87–105
   Google Scholar
• Chen L., Ashe S., Brady W. A., Hellstrom I., Hellstrom K. E., Ledbetter J. A., McGowan P., Linsley P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093–1102
   PubMed Web of Science ®Google Scholar
• Townsend S. E., Allison J. P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993; 259: 368–370
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Wallace P. M., Johnson J., Gibson M. G., Greene J. L., Ledbetter J. A., Singh C., Tepper M. A. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992; 257: 792–795
   PubMed Web of Science ®Google Scholar
• Ronchese F., Hausmann B., Hubele S., Lane P. Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo. J. Exp. Med 1994; 179: 809–817
   PubMed Web of Science ®Google Scholar
• Lane P., Burdet C., Hubele S., Scheidegger D., Müller U., McConnel F., Kosco-Vilbois M. B cell function in mice transgenic for mCTLA4-Hγ1: lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J. Exp. Med 1994; 179: 819–830
   PubMedGoogle Scholar
• Lenschow D. J., Zeng Y., Thistlethwaite J. R., Montag A., Brady W., Gibson M. G., Linsley P. S., Bluestone J. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4 Ig. Science 1992; 257: 789–792
   PubMed Web of Science ®Google Scholar
• Lafferty K. J., Prowse S. J., Simeonovic C. J. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Annu. Rev. Immunol 1983; 1: 143–173
   PubMed Web of Science ®Google Scholar
• Turka L. A., Linsley P. S., Lin H., Brady W., Leiden J. M., Wei R. -Q., Gibson M. L., Zheng X. G., Myrdal S., Gordon D. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 1992; 89: 11102–11106
   PubMed Web of Science ®Google Scholar
• Lin H., Boiling S. F., Linsley P. S., Wei R. -Q., Gordon D., Thompson C. B., Turka L. A. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4 Ig plus donor specific transfusion. J. Exp. Med 1993; 178: 1801–1806
   PubMed Web of Science ®Google Scholar
• Guerder S., Picarella D. E., Linsley P. S., Flavell R. A. Costimulator B7–1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 1994; 91: 5138–5142
   PubMed Web of Science ®Google Scholar
• Harlan D., Hengartner H., Huang M., Kang Y. -H., Abe R., Moreadith R., Pircher H., Gray G., Ohashi P., Freeman G., Nadler L., June C., Aichele P. Mice expressing both B7–1 and viral glycoprotein on pancreatic beta cells along with glycoprotein specific transgenic T cells develop diabetes due to a breakdown of T-lymphocytes unresponsiveness. Proc. Natl. Acad. Sci. USA 1994; 91: 3137–3141
   PubMed Web of Science ®Google Scholar
• Williams I. R., Ort R. J., Kupper T. S. Keratinocytes expression of B7–1 in transgenic mice amplifies the primary response to cutaneous antigens. Proc. Natl. Acad. Sci. USA 1994; 91: 12780–12784
   PubMed Web of Science ®Google Scholar
• Guerder S., Meyerhoff J., Flavell R. The role of the T cell costimulator B7–1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1994; 1: 1–20
   Google Scholar
• Morahan G., Allison J., Miller J. F. A. P. Tolerance of class I histocompatability antigens expressed extrathymically. Nature 1989; 339: 622–624
   PubMed Web of Science ®Google Scholar
• Heath W. R., Allison J., Hoffmann M. W., Schonrich G., Hammerling G., Arnold B., Miller J. F. A. P. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 1992; 359: 547–549
   PubMed Web of Science ®Google Scholar
• Picarella D. E., Kratz A., Li C. -b., Ruddle N. H., Flavell R. A. Transgenic tumor necrosis factor (TNF)-a production in pancreatic islets leads to insulitis, not diabetes. J. Immunol 1993; 150: 4136–4150
   PubMedGoogle Scholar
• Higuchi Y., Herrera P., Muniesa P., Huarte J., Belin D., Ohashi P., Aichele P., Orci L., Vassalli J. -D., Vassalli P. Expression of a tumor necrosis factor α transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med 1992; 176: 1719–1731
   PubMed Web of Science ®Google Scholar
• Nickoloff B. J., Mitra R. S., Lee K., Turka L. A., Green J., Thompson C., Shimizu Y. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol 1993; 142: 1029–1040
   PubMed Web of Science ®Google Scholar
• Wong S., Guerder S., Visintin I., Reich E. -P., Swenson K. E., Flavell R. A., Janeway C. A.J. Expression of the Co-stimulatory Molecule B7–1 in Pancreatic β-cells Accelerates Diabetes in the NOD Mouse. Diabetes 1995; 44: 326–329
   PubMedGoogle Scholar
• Fields L. E., Loh D. Y. Organ injury associated with extrathymic induction of immune tolerance in doubly transgenic mice. Proc. Natl. Acad. Sci. USA 1992; 89: 5730–5734
   PubMed Web of Science ®Google Scholar
• Schonrich G., Kalinke U., Momburg E., Malissen M., Hammerling G. J., Arnold B. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65: 293–304
   PubMed Web of Science ®Google Scholar
• Lo D., Burkly L. C., Flavell R. A., Palmiter R. D., Brinster R. L. Tolerance in transgenic mice expressing class II major histocompatability complex on pancreatic acinar cells. J. Exp. Med 1989; 170: 87–104
   PubMed Web of Science ®Google Scholar
• Lo D., Burkly L. C., Widera G., Cowing C., Flavell R. A., Palmiter R. D., Brinster R. L. 1988. Diabetes and tolerance in transgenic mice expressing class IIMHC molecules in pancreatic beta cells. Cell 1988; 53: 159–168
   PubMed Web of Science ®Google Scholar
• Ohashi P. L., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305–317
   PubMed Web of Science ®Google Scholar
• Oldstone M. B. A., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 1991; 65: 319–331
   PubMed Web of Science ®Google Scholar
• Ohashi P. S., Oehen S., Aichele P., Pircher H., Odermatt B., Herrera P., Higuchi Y., Buerki K., Hengartner H., Zinkernagel R. M. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α. J. Immunol 1993; 150: 5185–5194
   PubMed Web of Science ®Google Scholar
• Kuchroo V. K., Das M. P., Brown J. A., Ranger A. M., Zamvil S. S., Sobel R. A., Weiner H. L., Nabavi N., Glimcher L. H. B7–1 and B7–2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707–718
   PubMed Web of Science ®Google Scholar
• Todd J. A., Aitman T. J., Cornall R. J., Ghosh S., Hall J. R. S., Hearne C. M., Knight A. M., Love J. M., McAleer M. A., Prins J. -B., Rodrigues N., Lathrop M., Pressey A., DeLarato N. H., Wicker L. S. Genetic analysis of type I autoimmune diabetes mellitus in mice. Nature 1991; 351: 542–547
   PubMed Web of Science ®Google Scholar